| Metric | Q3 2021 | Q2 2021 | Q3 2020 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $162M | $150M | $151M | 8.2% | 7.1% |
| Op. Income | $15M | $12M | $13M | 29.6% | 18.0% |
| Gross Margin | 27.0% | 25.5% | 24.1% | 1.5pp | 2.9pp |
| Net Margin | -1.3% | 2.6% | -2.6% | -3.8pp | 1.4pp |
| EPS (Diluted) | $-0.02 | $0.03 | $-0.03 | -152.3% | 47.5% |
| Free Cash Flow | $78M | $65M | $64M | 19.9% | 22.5% |
| Item | Amount |
|---|---|
| REVENUE | $162M |
| Cost of Revenue | $118M |
| GROSS PROFIT | $44M |
| R&D Expenses | $3M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $26M |
| Other Expenses | $0 |
| Operating Expenses | $29M |
| Cost & Expenses | $147M |
| OPERATING INCOME | $15M |
| Interest Income | $848.0K |
| Interest Expense | $18M |
| Other Income/Expenses | -$19M |
| INCOME BEFORE TAX | -$4M |
| Income Tax Expense | -$1M |
| Net Income from Continuing Ops | -$2M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | -$2M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | -$2M |
| D&A | $78M |
| EBIT | $15M |
| EBITDA | $93M |
| EPS | -$0 |
| EPS Diluted | -$0 |
| Item | Amount |
|---|---|
| Net Income | -$2M |
| Depreciation & Amortization | $78M |
| Stock-Based Compensation | $8M |
| Deferred Income Tax | -$2M |
| Other Non-Cash Items | $2M |
| Change in Working Capital | $4M |
| OPERATING CASH FLOW | $87M |
| Capital Expenditure | -$9M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $4M |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$5M |
| Net Debt Issuance | -$4M |
| Common Stock Repurchased | -$3M |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$2M |
| NET CASH FROM FINANCING | -$9M |
| FREE CASH FLOW | $78M |
| Net Change in Cash | $74M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $287M |
| Short-Term Investments | $2M |
| Net Receivables | $70M |
| Inventory | $23M |
| Other Current Assets | $10M |
| TOTAL CURRENT ASSETS | $393M |
| PP&E (Net) | $2.7B |
| Goodwill | $0 |
| Intangible Assets | $44M |
| Long-Term Investments | $2M |
| Tax Assets | $0 |
| Other Non-Current Assets | $46M |
| TOTAL NON-CURRENT ASSETS | $2.8B |
| TOTAL ASSETS | $3.2B |
| Account Payables | $11M |
| Short-Term Debt | $17M |
| Deferred Revenue | $26M |
| Other Current Liabilities | $40M |
| TOTAL CURRENT LIABILITIES | $93M |
| Long-Term Debt | $1.6B |
| Deferred Revenue NC | $49M |
| Deferred Tax Liabilities | $135M |
| Other Non-Current Liabilities | $22M |
| TOTAL NON-CURRENT LIABILITIES | $1.8B |
| TOTAL LIABILITIES | $1.9B |
| Common Stock | $132.0K |
| Additional Paid-In Capital | $1.2B |
| Retained Earnings | $176M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$10M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.3B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.3B |
| TOTAL LIABILITIES & EQUITY | $3.2B |
| Total Debt | $1.6B |
| Net Debt | $1.3B |
